Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2022 Volume 24 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy

  • Authors:
    • Yanjie You
    • Fangrui Hu
    • Shengjuan Hu
  • View Affiliations / Copyright

    Affiliations: Department of Gastroenterology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia Hui Autonomous Region 750002, P.R. China
    Copyright: © You et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 224
    |
    Published online on: May 25, 2022
       https://doi.org/10.3892/ol.2022.13345
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The zinc‑fingers and homeoboxes (ZHX) family members have been characterized as master regulators in cancer initiation and development. The present study performed in silico data‑mining with publicly available datasets and immunohistochemistry to assess the expression status of ZHX factors and the corresponding prognostic implications in liver cancer. Increased ZHX3 mRNA expression was associated with favorable overall survival in patients with liver cancer. Subgroups analyses revealed a significant association between the expression of ZHX factors and outcomes in select patient cohorts. Immunohistochemical analysis supported that ZHX3 expression was an independent prognostic indicator for patient survival. These results suggested that dysregulation of ZHX factors is involved in disease progression and ZHX3 expression may serve as a prognostic biomarker for liver cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Yu J, Tao Q, Cheung KF, Jin H, Poon FF, Wang X, Li H, Cheng YY, Röcken C, Ebert MP, et al: Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology. 48:508–518. 2008. View Article : Google Scholar : PubMed/NCBI

3 

You Y, Ma Y, Wang Q, Ye Z, Deng Y and Bai F: Attenuated ZHX3 expression serves as a potential biomarker that predicts poor clinical outcomes in breast cancer patients. Cancer Manag Res. 11:1199–1210. 2019. View Article : Google Scholar : PubMed/NCBI

4 

You Y, Bai F, Li H, Ma Y, Yao L, Hu J and Tian Y: Prognostic value and therapeutic implications of ZHX family member expression in human gastric cancer. Am J Transl Res. 12:3376–3388. 2020.PubMed/NCBI

5 

Liu Y, Ma D and Ji C: Zinc fingers and homeoboxes family in human diseases. Cancer Gene Ther. 22:223–226. 2015. View Article : Google Scholar : PubMed/NCBI

6 

Barthelemy I, Carramolino L, Gutiérrez J, Barbero JL, Márquez G and Zaballos A: A novel mouse homeodomain protein containing two zinc-fingers and five homeodomains. Biochem Biophys Res Commun. 224:870–876. 1996. View Article : Google Scholar : PubMed/NCBI

7 

Hirano S, Yamada K, Kawata H, Shou Z, Mizutani T, Yazawa T, Kajitani T, Sekiguchi T, Yoshino M, Shigematsu Y, et al: Rat zinc-fingers and homeoboxes 1 (ZHX1), a nuclear factor-YA-interacting nuclear protein, forms a homodimer. Gene. 290:107–114. 2002. View Article : Google Scholar : PubMed/NCBI

8 

Kawata H, Yamada K, Shou Z, Mizutani T, Yazawa T, Yoshino M, Sekiguchi T, Kajitani T and Miyamoto K: Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. Biochem J. 373:747–757. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Yamada K, Kawata H, Shou Z, Hirano S, Mizutani T, Yazawa T, Sekiguchi T, Yoshino M, Kajitani T and Miyamoto K: Analysis of zinc-fingers and homeoboxes (ZHX)-1-interacting proteins: Molecular cloning and characterization of a member of the ZHX family, ZHX3. Biochem J. 373:167–178. 2003. View Article : Google Scholar : PubMed/NCBI

10 

Kawata H, Yamada K, Shou Z, Mizutani T and Miyamoto K: The mouse zinc-fingers and homeoboxes (ZHX) family; ZHX2 forms a heterodimer with ZHX3. Gene. 323:133–140. 2003. View Article : Google Scholar : PubMed/NCBI

11 

Suehiro F, Nishimura M, Kawamoto T, Kanawa M, Yoshizawa Y, Murata H and Kato Y: Impact of zinc fingers and homeoboxes 3 on the regulation of mesenchymal stem cell osteogenic differentiation. Stem Cells Dev. 20:1539–1547. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Liu G, Clement LC, Kanwar YS, Avila-Casado C and Chugh SS: ZHX proteins regulate podocyte gene expression during the development of nephrotic syndrome. J Biol Chem. 281:39681–39692. 2006. View Article : Google Scholar : PubMed/NCBI

13 

Clement LC, Liu G, Perez-Torres I, Kanwar YS, Avila-Casado C and Chugh SS: Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int. 72:337–347. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Nagel S, Ehrentraut S, Meyer C, Kaufmann M, Drexler HG and MacLeod RA: Aberrantly expressed OTX homeobox genes deregulate B-cell differentiation in hodgkin lymphoma. PLoS One. 10:e01384162015. View Article : Google Scholar : PubMed/NCBI

15 

Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A and Chinnaiyan AM: ONCOMINE: A cancer microarray database and integrated data-mining platform. Neoplasia. 6:1–6. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B and Liu XS: TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 77:e108–e110. 2017. View Article : Google Scholar : PubMed/NCBI

17 

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV, Sonkin D, et al: The cancer cell line encyclopedia enables predictive modelling of anticancerdrug sensitivity. Nature. 483:603–607. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Lanczky A, Nagy A, Bottai G, Munkacsy G, Szabo A, Santarpia L and Gyorffy B: miRpower: A web-tool to validate survival-associated miRNAs utilizing expression data from 2,178 breast cancer patients. Breast Cancer Res Treat. 160:439–446. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Szász AM, Lánczky A, Nagy Á, Förster S, Hark K, Green JE, Boussioutas A, Busuttil R, Szabó A and Győrffy B: Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients. Oncotarget. 7:49322–49333. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 6:pl12013. View Article : Google Scholar : PubMed/NCBI

21 

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al: The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2:401–404. 2012. View Article : Google Scholar : PubMed/NCBI

22 

You Y, Li H, Qin X, Zhang Y, Song W, Ran Y and Gao F: Decreased CDK10 expression correlates with lymph node metastasis and predicts poor outcome in breast cancer patients - a short report. Cell Oncol (Dordr). 38:485–491. 2015. View Article : Google Scholar : PubMed/NCBI

23 

You Y, Li H, Qin X, Ran Y and Wang F.: Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis-A short report. Cell Oncol (Dordr). 39:89–95. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Wang J, Liu D, Liang X, Gao L, Yue X, Yang Y, Ma C and Liu J: Construction of a recombinant eukaryotic human ZHX1 gene expression plasmid and the role of ZHX1 in hepatocellular carcinoma. Mol Med Rep. 8:1531–1536. 2013. View Article : Google Scholar : PubMed/NCBI

25 

Wang Z, Ma X, Cai Q, Wang X, Yu B, Cai Q, liu B, Zhu Z and Li C: MiR-199a-3p promotes gastric cancer progression by targeting ZHX1. FEBS Lett. 588:4504–4512. 2014. View Article : Google Scholar : PubMed/NCBI

26 

Ma X, Huang M, Wang Z, Liu B, Zhu Z and Li C: ZHX1 inhibits gastric cancer cell growth through inducing cell-cycle arrest and apoptosis. J Cancer. 7:60–68. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Kwon RJ, Kim YH, Jeong DC, Han ME, Kim JY, Liu L, Jung JS and Oh SO: Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma. PLoS One. 12:e01710362017. View Article : Google Scholar : PubMed/NCBI

28 

Guan J, Liu Z, Xiao M, Hao F, Wang C, Chen Y, Lu Y and Liang J: MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal. Am J Transl Res. 9:2457–2465. 2017.PubMed/NCBI

29 

Kwon RJ, Han ME, Kim JY, Liu L, Kim YH, Jung JS and Oh SO: ZHX1 promotes the proliferation, migration and invasion of cholangiocarcinoma cells. PLoS One. 11:e01655162016. View Article : Google Scholar : PubMed/NCBI

30 

Kwon RJ, Han ME, Kim YJ, Kim YH, Kim JY, Liu L, Heo W and Oh SO: Roles of zinc-fingers and homeoboxes 1 during the proliferation, migration, and invasion of glioblastoma cells. Tumour Biol. 39:10104283176945752017. View Article : Google Scholar : PubMed/NCBI

31 

Yamada K, Ogata-Kawata H, Matsuura K, Kagawa N, Takagi K, Asano K, Haneishi A and Miyamoto K: ZHX2 and ZHX3 repress cancer markers in normal hepatocytes. Front Biosci (Landmark Ed). 14:3724–3732. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Lv Z, Zhang M, Bi J, Xu F, Hu S and Wen J: Promoter hypermethylation of a novel gene, ZHX2, in hepatocellular carcinoma. Am J Clin Pathol. 125:740–746. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, Liu X, Ma H, Guo M, Spear BT, et al: Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of cyclins A and E. Gastroenterology. 142:1559–1570.e2. 2012. View Article : Google Scholar : PubMed/NCBI

34 

Luan F, Liu P, Ma H, Yue X, Liu J, Gao L, Liang X and Ma C: Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. Int J Biochem Cell Biol. 55:129–135. 2014. View Article : Google Scholar : PubMed/NCBI

35 

Song X, Tan S, Wu Z, Xu L, Wang Z, Xu Y, Wang T, Gao C, Gong Y, Liang X, et al: HBV suppresses ZHX2 expression to promote proliferation of HCC through miR-155 activation. Int J Cancer. 143:3120–3130. 2018. View Article : Google Scholar : PubMed/NCBI

36 

Xu L, Wu Z, Tan S, Wang Z, Lin Q, Li X, Song X, Liu Y, Song Y, Zhang J, et al: Tumor suppressor ZHX2 restricts hepatitis B virus replication via epigenetic and non-epigenetic manners. Antiviral Res. 153:114–123. 2018. View Article : Google Scholar : PubMed/NCBI

37 

Hu S, Zhang M, Lv Z, Bi J, Dong Y and Wen J: Expression of zinc-fingers and homeoboxes 2 in hepatocellular carcinogenesis: A tissue microarray and clinicopathological analysis. Neoplasma. 54:207–211. 2007.PubMed/NCBI

38 

Armellini A, Sarasquete ME, García-Sanz R, Chillón MC, Balanzategui A, Alcoceba M, Fuertes M, López R, Hernández JM, Fernández-Calvo J, et al: Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. Br J Haematol. 141:212–215. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
You Y, Hu F and Hu S: Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncol Lett 24: 224, 2022.
APA
You, Y., Hu, F., & Hu, S. (2022). Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncology Letters, 24, 224. https://doi.org/10.3892/ol.2022.13345
MLA
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24.1 (2022): 224.
Chicago
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24, no. 1 (2022): 224. https://doi.org/10.3892/ol.2022.13345
Copy and paste a formatted citation
x
Spandidos Publications style
You Y, Hu F and Hu S: Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncol Lett 24: 224, 2022.
APA
You, Y., Hu, F., & Hu, S. (2022). Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy. Oncology Letters, 24, 224. https://doi.org/10.3892/ol.2022.13345
MLA
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24.1 (2022): 224.
Chicago
You, Y., Hu, F., Hu, S."Attenuated ZHX3 expression is predictive of poor outcome for liver cancer: Indication for personalized therapy". Oncology Letters 24, no. 1 (2022): 224. https://doi.org/10.3892/ol.2022.13345
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team